BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Steinhagen F, Schmidt SV, Schewe JC, Peukert K, Klinman DM, Bode C. Immunotherapy in sepsis - brake or accelerate? Pharmacol Ther 2020;208:107476. [PMID: 31931100 DOI: 10.1016/j.pharmthera.2020.107476] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Feng Y, Huang W, Paul C, Liu X, Sadayappan S, Wang Y, Pauklin S. Mitochondrial nucleoid in cardiac homeostasis: bidirectional signaling of mitochondria and nucleus in cardiac diseases. Basic Res Cardiol 2021;116:49. [PMID: 34392401 DOI: 10.1007/s00395-021-00889-1] [Reference Citation Analysis]
2 Dellinger RP, Levy MM, Schorr CA, Townsend SR. The authors reply. Crit Care Med 2022;50:e335-6. [PMID: 35191890 DOI: 10.1097/CCM.0000000000005406] [Reference Citation Analysis]
3 Federico S, Pozzetti L, Papa A, Carullo G, Gemma S, Butini S, Campiani G, Relitti N. Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists. J Med Chem 2020;63:13466-513. [PMID: 32845153 DOI: 10.1021/acs.jmedchem.0c01049] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
4 Li N, Wu S, Yu L. The associations of long non-coding RNA taurine upregulated gene 1 and microRNA-223 with general disease severity and mortality risk in sepsis patients. Medicine (Baltimore) 2020;99:e23444. [PMID: 33327275 DOI: 10.1097/MD.0000000000023444] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Qiu P, Zhou J, Zhang J, Dong Y, Liu Y. Exosome: The Regulator of the Immune System in Sepsis. Front Pharmacol 2021;12:671164. [PMID: 33995102 DOI: 10.3389/fphar.2021.671164] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 David S, Bode C, Putensen C, Welte T, Stahl K; EXCHANGE study group. Adjuvant therapeutic plasma exchange in septic shock. Intensive Care Med 2021;47:352-4. [PMID: 33471132 DOI: 10.1007/s00134-020-06339-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Sebastian A, Sanju S, Jain P, Priya VV, Varma PK, Mony U. Non-classical monocytes and its potential in diagnosing sepsis post cardiac surgery. Int Immunopharmacol 2021;99:108037. [PMID: 34426113 DOI: 10.1016/j.intimp.2021.108037] [Reference Citation Analysis]
8 Preethy S, Raghavan K, Dedeepiya VD, Surya Prakash V, Ikewaki N, Ikeue Y, Nagataki M, Iwasaki M, Senthilkumar R, Abraham SJK. Beneficial Immune Regulation by Biological Response Modifier Glucans in COVID-19 and Their Envisaged Potentials in the Management of Sepsis. Front Immunol 2022;13:870632. [DOI: 10.3389/fimmu.2022.870632] [Reference Citation Analysis]
9 Li Y, Zhang H, Chen C, Qiao K, Li Z, Han J, Han X, Li K, Lai K, Liu N, Li A, Xiao N, Zhang Y, Zhao X, Gao W, Zhang Y, Liu H, Sun T. Biomimetic Immunosuppressive Exosomes that Inhibit Cytokine Storms Contribute to the Alleviation of Sepsis. Adv Mater 2022;34:e2108476. [PMID: 35267211 DOI: 10.1002/adma.202108476] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Leong K, Gaglani B, Khanna AK, McCurdy MT. Novel Diagnostics and Therapeutics in Sepsis. Biomedicines 2021;9:311. [PMID: 33803628 DOI: 10.3390/biomedicines9030311] [Reference Citation Analysis]
11 Liang G, He Z. High Mobility Group Proteins in Sepsis. Front Immunol 2022;13:911152. [PMID: 35720285 DOI: 10.3389/fimmu.2022.911152] [Reference Citation Analysis]
12 Valenzuela-méndez B, Valenzuela-sánchez F, Rodríguez-gutiérrez JF, Bohollo-de-austria R, Estella Á, Martínez-garcía P, Ángela González-garcía M, Waterer G, Rello J. Host response dysregulations amongst adults hospitalized by influenza A H1N1 virus pneumonia: A prospective multicenter cohort study. European Journal of Internal Medicine 2022. [DOI: 10.1016/j.ejim.2022.07.010] [Reference Citation Analysis]
13 Lu J, Chen R, Ou Y, Jiang Q, Wang L, Liu G, Liu Y, Yang B, Zhou Z, Zuo L, Chen Z. Characterization of immune-related genes andimmune infiltration features for early diagnosis, prognosis and recognition of immunosuppression in sepsis. Int Immunopharmacol 2022;107:108650. [PMID: 35272172 DOI: 10.1016/j.intimp.2022.108650] [Reference Citation Analysis]
14 Stavropoulou E, Bezirtzoglou E. Probiotics in Medicine: A Long Debate. Front Immunol 2020;11:2192. [PMID: 33072084 DOI: 10.3389/fimmu.2020.02192] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
15 Han H, Kim S, Shin J, Lee H, Chung K, Rhee YK, Cho C, Hong H, Lee K. Polysaccharide fraction isolated from the leaves of Hordeum vulgare L. protects against colonic inflammation of systemic immune responses. Journal of Functional Foods 2021;87:104765. [DOI: 10.1016/j.jff.2021.104765] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Stavropoulou E, Bezirtzoglou E. Probiotics as a Weapon in the Fight Against COVID-19. Front Nutr 2020;7:614986. [PMID: 33385008 DOI: 10.3389/fnut.2020.614986] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
17 Olwal CO, Nganyewo NN, Tapela K, Djomkam Zune AL, Owoicho O, Bediako Y, Duodu S. Parallels in Sepsis and COVID-19 Conditions: Implications for Managing Severe COVID-19. Front Immunol 2021;12:602848. [PMID: 33613574 DOI: 10.3389/fimmu.2021.602848] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
18 Keshavarz A, Pourbagheri-Sigaroodi A, Zafari P, Bagheri N, Ghaffari SH, Bashash D. Toll-like receptors (TLRs) in cancer; with an extensive focus on TLR agonists and antagonists. IUBMB Life 2021;73:10-25. [PMID: 33217774 DOI: 10.1002/iub.2412] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
19 Nowill AE, de Campos-Lima PO. Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm. J Immunol 2020;205:2566-75. [PMID: 32958687 DOI: 10.4049/jimmunol.2000892] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
20 Wang G, Li X, Zhang L, Elgaili Abdalla A, Teng T, Li Y. Crosstalk between Dendritic Cells and Immune Modulatory Agents against Sepsis. Genes (Basel) 2020;11:E323. [PMID: 32197507 DOI: 10.3390/genes11030323] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Morris G, Puri BK, Olive L, Carvalho A, Berk M, Walder K, Gustad LT, Maes M. Endothelial dysfunction in neuroprogressive disorders-causes and suggested treatments. BMC Med 2020;18:305. [PMID: 33070778 DOI: 10.1186/s12916-020-01749-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
22 Chen Z, Chen R, Ou Y, Lu J, Jiang Q, Liu G, Wang L, Liu Y, Zhou Z, Yang B, Zuo L. Construction of an HLA Classifier for Early Diagnosis, Prognosis, and Recognition of Immunosuppression in Sepsis by Multiple Transcriptome Datasets. Front Physiol 2022;13:870657. [PMID: 35685286 DOI: 10.3389/fphys.2022.870657] [Reference Citation Analysis]
23 Yin Y, Xu N, Shi Y, Zhou B, Sun D, Ma B, Xu Z, Yang J, Li C. Astaxanthin Protects Dendritic Cells from Lipopolysaccharide-Induced Immune Dysfunction. Mar Drugs 2021;19:346. [PMID: 34204220 DOI: 10.3390/md19060346] [Reference Citation Analysis]
24 Moriyama K, Nishida O. Targeting Cytokines, Pathogen-Associated Molecular Patterns, and Damage-Associated Molecular Patterns in Sepsis via Blood Purification. Int J Mol Sci 2021;22:8882. [PMID: 34445610 DOI: 10.3390/ijms22168882] [Reference Citation Analysis]
25 Ou AT, Zhang JX, Fang YF, Wang R, Tang XP, Zhao PF, Zhao YG, Zhang M, Huang YZ. Disulfiram-loaded lactoferrin nanoparticles for treating inflammatory diseases. Acta Pharmacol Sin 2021;42:1913-20. [PMID: 34561552 DOI: 10.1038/s41401-021-00770-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
26 Slim MA, van Mourik N, Dionne JC, Oczkowski SJW, Netea MG, Pickkers P, Giamarellos-Bourboulis EJ, Müller MCA, van der Poll T, Wiersinga WJ, Vlaar APJ, van Vught LA. Personalised immunotherapy in sepsis: a scoping review protocol. BMJ Open 2022;12:e060411. [PMID: 35534059 DOI: 10.1136/bmjopen-2021-060411] [Reference Citation Analysis]
27 Wang J, Yin Y, Xu N, Zhou B, Qin T. Royal jelly attenuates LPS-induced immune dysfunction of dendritic cells via Nrf2/HO-1 axis. Journal of Functional Foods 2022;95:105191. [DOI: 10.1016/j.jff.2022.105191] [Reference Citation Analysis]
28 Bezirtzoglou E, Stavropoulou E, Kantartzi K, Tsigalou C, Voidarou C, Mitropoulou G, Prapa I, Santarmaki V, Kompoura V, Yanni AE, Antoniadou M, Varzakas T, Kourkoutas Y. Maintaining Digestive Health in Diabetes: The Role of the Gut Microbiome and the Challenge of Functional Foods. Microorganisms 2021;9:516. [PMID: 33802371 DOI: 10.3390/microorganisms9030516] [Reference Citation Analysis]
29 Lu F, Hong Y, Liu L, Wei N, Lin Y, He J, Shao Y. Long noncoding RNAs: A potential target in sepsis-induced cellular disorder. Exp Cell Res 2021;406:112756. [PMID: 34384779 DOI: 10.1016/j.yexcr.2021.112756] [Reference Citation Analysis]
30 Stahl K, Wand P, Seeliger B, Wendel-Garcia PD, Schmidt JJ, Schmidt BMW, Sauer A, Lehmann F, Budde U, Busch M, Wiesner O, Welte T, Haller H, Wedemeyer H, Putensen C, Hoeper MM, Bode C, David S. Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trial. Crit Care 2022;26:134. [PMID: 35551628 DOI: 10.1186/s13054-022-04003-2] [Reference Citation Analysis]
31 Cornelius DC, Travis OK, Tramel RW, Borges-Rodriguez M, Baik CH, Greer M, Giachelli CA, Tardo GA, Williams JM. NLRP3 inflammasome inhibition attenuates sepsis-induced platelet activation and prevents multi-organ injury in cecal-ligation puncture. PLoS One 2020;15:e0234039. [PMID: 32555710 DOI: 10.1371/journal.pone.0234039] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
32 Corica B, Romiti GF, Basili S, Proietti M. Prevalence of New-Onset Atrial Fibrillation and Associated Outcomes in Patients with Sepsis: A Systematic Review and Meta-Analysis. JPM 2022;12:547. [DOI: 10.3390/jpm12040547] [Reference Citation Analysis]
33 Nedeva C. Inflammation and Cell Death of the Innate and Adaptive Immune System during Sepsis. Biomolecules 2021;11:1011. [PMID: 34356636 DOI: 10.3390/biom11071011] [Reference Citation Analysis]
34 Morris G, Bortolasci CC, Puri BK, Olive L, Marx W, O'Neil A, Athan E, Carvalho AF, Maes M, Walder K, Berk M. The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach. Life Sci. 2020;258:118166. [PMID: 32739471 DOI: 10.1016/j.lfs.2020.118166] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
35 Zhu L, Shi D, Cao J, Song L. LncRNA CASC2 Alleviates Sepsis-induced Acute Lung Injury by Regulating the miR-152-3p/PDK4 Axis. Immunol Invest 2021;:1-15. [PMID: 34165388 DOI: 10.1080/08820139.2021.1928693] [Reference Citation Analysis]
36 Hajam IA, Ali F, Young J, Garcia MA, Cannavino C, Ramchandar N, Liu GY. Anti-Inflammatory Properties of Plasma from Children with Short Bowel Syndrome. Pathogens 2021;10:1021. [PMID: 34451485 DOI: 10.3390/pathogens10081021] [Reference Citation Analysis]